The role of positron emission tomography in management of small cell lung cancer

被引：32

作者：

Thomson, D. ^{[1
]}

Hulse, P. ^{[2
]}

Lorigan, P. ^{[3
]}

Faivre-Finn, C. ^{[1
]}

机构：

[1] Christie NHS Fdn Trust, Dept Clin Oncol, Manchester M20 4BX, Lancs, England

[2] Christie NHS Fdn Trust, Dept Radiol, Manchester M20 4BX, Lancs, England

[3] Christie NHS Fdn Trust, Dept Med Oncol, Manchester M20 4BX, Lancs, England

来源：

LUNG CANCER | 2011年 / 73卷 / 02期

关键词：

Lung cancer; Small-cell lung cancer; Positron emission tomography; PET; FDG-PET; PET-CT; CLINICAL-PRACTICE GUIDELINES; PHASE-III TRIAL; BODY FDG-PET; RESPONSE EVALUATION; THORACIC RADIOTHERAPY; TNM-CLASSIFICATION; PROGNOSTIC-FACTORS; F-18-FDG PET; DIAGNOSIS; CT;

D O I：

10.1016/j.lungcan.2011.03.013

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Accurate radiological staging of small-cell lung cancer (SCLC) is of paramount importance in selection of individual patients with limited stage disease for potentially curative treatment while avoiding toxic treatment in those with distant metastatic disease. [F-18] flurodeoxy-o-glucose (FDG) positron emission tomography (PET) is an attractive tool for this purpose but there is limited evidence to support its use in the routine staging of SCLC. Whether therapeutic decisions based on FDG-PET imaging should be made remains uncertain. There is only preliminary evidence for use of FDG-PET as a prognostic biomarker, in the assessment of response to treatment and delineation of disease in conformal radiation planning. (C) 2011 Elsevier Ireland Ltd. All rights reserved.

引用

页码：121 / 126

页数：6

共 50 条

[31] Positron emission tomography scanning for the diagnosis and management of lung cancer
Line B.R.
White C.S.
Current Treatment Options in Oncology, 2004, 5 (1) : 63 - 73
[32] The role of positron emission tomography in germ cell cancer
De Santis, M
Pont, J
WORLD JOURNAL OF UROLOGY, 2004, 22 (01) : 41 - 46
[33] Positron emission tomography: Lung cancer
Hagge, RJ
Coleman, RE
SEMINARS IN ROENTGENOLOGY, 2002, 37 (02) : 110 - 117
[34] Positron emission tomography in lung cancer
Shon, IH
O'Doherty, MJ
Maisey, MN
SEMINARS IN NUCLEAR MEDICINE, 2002, 32 (04) : 240 - 271
[35] Positron emission tomography in lung cancer
Nomori H.
Ohba Y.
Yoshimoto K.
Shibata H.
Shiraishi K.
Mori T.
General Thoracic and Cardiovascular Surgery, 2009, 57 (4) : 184 - 191
[36] Positron emission tomography in lung cancer
Lowe, VJ
Naunheim, KS
ANNALS OF THORACIC SURGERY, 1998, 65 (06): : 1821 - 1829
[37] The clinical impact of positron emission tomography (PET) scanning on the staging and management of non small cell lung cancer (NSCLC)
Mackay, A. J.
Docherty, C.
Beckles, M.
Buscombe, J.
LUNG CANCER, 2007, 57 : S1 - S1
[38] Impact of FDG-labelled positron emission tomography imaging on the management of non-small-cell lung cancer
Salminen, E
Mac Manus, M
ANNALS OF MEDICINE, 2001, 33 (06) : 404 - 409
[39] The Role of Integrated Positron Emission Tomography-Computerized Tomography in Evaluating and Staging Patients with Non-Small Cell Lung Cancer
Cerfolio, Robert James
Bryant, Ayesha S.
SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2007, 19 (03) : 192 - 200
[40] The role of integrated positron emission tomography and computed tomography in the assessment of nodal spread in cases with non-small cell lung cancer
Tasci, Erdal
Tezel, Cagatay
Orki, Alpay
Akin, Oral
Falay, Okan
Kutlu, Cemal Asim
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2010, 10 (02) : 200 - 203

← 1 2 3 4 5 →